Wird geladen...
The role of RBM10 mutations in the development, treatment, and prognosis of lung adenocarcinoma
RBM10 is the RNA-binding protein often absent or mutated in lung adenocarcinoma, rendering it as a potential biomarker or even therapeutic target to prolongate survival time. In this study, we investigated the involvement of RBM10 mutation in the pathogenesis and tumorigenesis of lung adenocarcinoma...
Gespeichert in:
| Veröffentlicht in: | Cell Cycle |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taylor & Francis
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7714495/ https://ncbi.nlm.nih.gov/pubmed/33064970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2020.1829801 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|